Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1981 Jul;45(1):81–89.

Neutrophil function in chronic liver disease.

A C Campbell, M W Dronfield, P J Toghill, W G Reeves
PMCID: PMC1537247  PMID: 7030541

Abstract

Neutrophil locomotion, phagocytosis and killing of Candida albicans, and plasma opsonization of brewer's yeast were studied in 44 out-patients with chronic liver disease. There were four diagnostic groups: alcoholic liver disease (ALD), chronic active hepatitis (CAH), primary biliary cirrhosis (PBC) and cryptogenic cirrhosis (CC). Results were compared with a control group of patients with non-malignant disorders of the upper alimentary tract. Neutrophil locomotion induced by zymosan-activated autologous plasma was significantly depressed in patients with ALD and, to a lesser extent, in cryptogenic cirrhosis. With plasma from healthy donors, the patients' neutrophils showed normal locomotion. Plasma from patients with CAH gave slightly but significantly reduced phagocytosis of both Candida albicans and brewer's yeast, but the patients' cells had normal phagocytic and killing activity in the presence of normal plasma. Thus, no intrinsic abnormality in neutrophil function was found in these patients, but plasma defects, which differed in cirrhoses of different underlying aetiology, led to impaired neutrophil locomotion or phagocytosis. No correlations were found between these plasma defects and circulating levels of C3, C4, immune complexes or IgA.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bridges C. G., Dasilva G. L., Yamamura M., Valdimarsson H. A radiometric assay for the combined measurement of phagocytosis and intracellular killing of Candida albicans. Clin Exp Immunol. 1980 Nov;42(2):226–233. [PMC free article] [PubMed] [Google Scholar]
  2. Burden R. P., Cotton R. E., Wallington T. B., Reeves W. G. Immune deposits in extraglomerular vessels: their correlation with circulating immune complexes. Clin Exp Immunol. 1980 Dec;42(3):483–489. [PMC free article] [PubMed] [Google Scholar]
  3. Conn H. O., Fessel J. M. Spontaneous bacterial peritonitis in cirrhosis: variations on a theme. Medicine (Baltimore) 1971 May;50(3):161–197. doi: 10.1097/00005792-197105000-00002. [DOI] [PubMed] [Google Scholar]
  4. DeMeo A. N., Andersen B. R. Defective chemotaxis associated with a serum inhibitor in cirrhotic patients. N Engl J Med. 1972 Apr 6;286(14):735–740. doi: 10.1056/NEJM197204062861401. [DOI] [PubMed] [Google Scholar]
  5. DuPont H. L., Spink W. W. Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966. Medicine (Baltimore) 1969 Jul;48(4):307–332. doi: 10.1097/00005792-196907000-00003. [DOI] [PubMed] [Google Scholar]
  6. Finlayson N. D., Krohn K., Fauconnet M. H., Anderson K. E. Significance of serum complement levels in chronic liver disease. Gastroenterology. 1972 Oct;63(4):653–659. [PubMed] [Google Scholar]
  7. Kemp A. S., Cripps A. W., Brown S. Suppression of leucocyte chemokinesis and chemotaxis by human IgA. Clin Exp Immunol. 1980 May;40(2):388–395. [PMC free article] [PubMed] [Google Scholar]
  8. Kourilsky O., Leroy C., Peltier A. P. Complement and liver cell function in 53 patients with liver disease. Am J Med. 1973 Dec;55(6):783–790. doi: 10.1016/0002-9343(73)90259-3. [DOI] [PubMed] [Google Scholar]
  9. Lufkin E. G., Silverman M., Callaway J. J., Glenchur H. Mixed septicemias and gastrointestinal disease. Am J Dig Dis. 1966 Dec;11(12):930–937. doi: 10.1007/BF02233081. [DOI] [PubMed] [Google Scholar]
  10. Maderazo E. C., Ward P. A., Quintiliani R. Defective regulation of chemotaxis in cirrhosis. J Lab Clin Med. 1975 Apr;85(4):621–630. [PubMed] [Google Scholar]
  11. Pagaltsos A. P., Smith M. G., Eddleston A. L., Williams R. Total haemolytic complement after liver transplantation and in liver disease. Transplantation. 1972 Jul;14(1):41–46. doi: 10.1097/00007890-197207000-00006. [DOI] [PubMed] [Google Scholar]
  12. RUTENBURG A. M., SONNENBLICK E., KOVEN I., SCHWEINBURG F., FINE J. Comparative response of normal and cirrhotic rats to intravenously injected bacteria. Proc Soc Exp Biol Med. 1959 Jun;101(2):279–281. doi: 10.3181/00379727-101-24910. [DOI] [PubMed] [Google Scholar]
  13. Thomas H. C. The immune response in hepatic cirrhosis: animal and human studies. Proc R Soc Med. 1977 Aug;70(8):521–525. [PMC free article] [PubMed] [Google Scholar]
  14. Thompson R. A., Carter R., Stokes R. P., Geddes A. M., Goodall J. A. Serum immunoglobulins, complement component levels and autoantibodies in liver disease. Clin Exp Immunol. 1973 Jul;14(3):335–346. [PMC free article] [PubMed] [Google Scholar]
  15. Uwaydah M. M., Weinberg A. N. Bacterial endocarditis--a changing pattern. N Engl J Med. 1965 Dec 2;273(23):1231–1235. doi: 10.1056/NEJM196512022732301. [DOI] [PubMed] [Google Scholar]
  16. Van Epps D. E., Strickland R. G., Williams R. C., Jr Inhibitors of leukocyte chemotaxis in alcoholic liver disease. Am J Med. 1975 Aug;59(2):200–207. doi: 10.1016/0002-9343(75)90354-x. [DOI] [PubMed] [Google Scholar]
  17. Van Epps D. E., Williams R. C., Jr Suppression of leukocyte chemotaxis by human IgA myeloma components. J Exp Med. 1976 Nov 2;144(5):1227–1242. doi: 10.1084/jem.144.5.1227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Weksler B. B., Hill M. J. Inhibition of leukocyte migration by a staphylococcal factor. J Bacteriol. 1969 Jun;98(3):1030–1035. doi: 10.1128/jb.98.3.1030-1035.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wyke R. J., Rajkovic I. A., Eddleston A. L., Williams R. Defective opsonisation and complement deficiency in serum from patients with fulminant hepatic failure. Gut. 1980 Aug;21(8):643–649. doi: 10.1136/gut.21.8.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Yamamura M., Boler J., Valdimarsson H. Phagocytosis measured as inhibition of uridine uptake by Candida albicans. J Immunol Methods. 1977;14(1):19–24. doi: 10.1016/s0022-1759(97)90016-8. [DOI] [PubMed] [Google Scholar]
  21. Yamamura M., Valdimarsson H. A new semiquantitative radiometric opsonin assay. Selective measurement of opsonizing capacity of the alternative pathway. Immunology. 1978 Apr;34(4):689–694. [PMC free article] [PubMed] [Google Scholar]
  22. Zigmond S. H., Hirsch J. G. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med. 1973 Feb 1;137(2):387–410. doi: 10.1084/jem.137.2.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Zubler R. H., Lange G., Lambert P. H., Miescher P. A. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus. J Immunol. 1976 Jan;116(1):232–235. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES